PRECEDE Biosamples help to validate Immunovia’s analytical validation of its next-generation pancreatic cancer test
Immunovia completes analytical validation of its next-generation pancreatic cancer test
Read MoreImmunovia completes analytical validation of its next-generation pancreatic cancer test
Read MoreThanks to your generous support, at the end of last year Curebound announced funding for three Cure Prizes including a…
Read MoreAfter the rigorous journey of pancreatic cancer treatment, survivors face a new chapter filled with its own set of challenges…
Read MorePancreatic cancer is one of the most aggressive and challenging cancers to diagnose and treat. Its unwanted distinction as the…
Read MoreClearNote Health joins the Pancreatic Cancer Early Detection (PRECEDE) Consortium in new partnership to reduce cancer mortality
Read MoreToday, I remain cancer-free, but I will always be looking over my shoulder for the next cancer to appear.
Read MoreThe PRECEDE study allowed me to be diagnosed at an early stage of pancreatic cancer and has given me hope…
Read MoreIβm on a mission to raise awareness in both the lay and medical communities of the importance of genetic testing…
Read MoreLymphoma and pancreatic cancer were discovered at early stages. I credit my self-awareness and proactive physicians for saving my life.
Read More